Acidosis-mediated increase in IFN-γ-induced PD-L1 expression on cancer cells as an immune escape mechanism in solid tumors

• Published in: Molecular cancer Vol. 22; no. 1; p. 207
• Main Authors: Knopf, Philipp, Stowbur, Dimitri, Hoffmann, Sabrina H L, Hermann, Natalie, Maurer, Andreas, Bucher, Valentina, Poxleitner, Marilena, Tako, Bredi, Sonanini, Dominik, Krishnamachary, Balaji, Sinharay, Sanhita, Fehrenbacher, Birgit, Gonzalez-Menendez, Irene, Reckmann, Felix, Bomze, David, Flatz, Lukas, Kramer, Daniela, Schaller, Martin, Forchhammer, Stephan, Bhujwalla, Zaver M, Quintanilla-Martinez, Leticia, Schulze-Osthoff, Klaus, Pagel, Mark D, Fransen, Marieke F, Röcken, Martin, Martins, André F, Pichler, Bernd J, Ghoreschi, Kamran, Kneilling, Manfred
• Format: Journal Article
• Language: English
• Published: England BioMed Central 15-12-2023; BMC
• Subjects: Acidosis; Animals; Apoptosis; B7-H1 Antigen; Biomarkers; Cancer therapies; Cell culture; Cell Line, Tumor; CRISPR; Drug resistance mechanisms in immunotherapy; Humans; Hypoxia; Immune checkpoint inhibitors; Immune evasion; Immunotherapy; Interferon-gamma - metabolism; Interferon-gamma - pharmacology; Kinases; Lung cancer; Lymphocytes; Lymphocytes T; Melanoma; Metastases; Mice; Modulators of tumor microenvironment; Neoplasms - genetics; Oncology; PD-1 protein; PD-L1 protein; Penicillin; pH modulation of the tumor microenvironment; Phosphorylation; Skin cancer; Sodium bicarbonate; Solid tumors; Stat1 protein; Tumor cell lines; Tumor Microenvironment; Tumors; γ-Interferon; United States > US; T-cells; Checkpoint inhibitors; Drug resistance mechanisms in immunotherapy; Immune response; Precision medicine; pH modulation of the tumor microenvironment; Immunotherapy; Modulators of tumor microenvironment; Biomarkers; Oncology; Immune checkpoint inhibitors; Combination therapy
• ISSN: 1476-4598; 1476-4598
• DOI: 10.1186/s12943-023-01900-0

Immune checkpoint inhibitors have revolutionized cancer therapy, yet the efficacy of these treatments is often limited by the heterogeneous and hypoxic tumor microenvironment (TME) of solid tumors. In the TME, programmed death-ligand 1 (PD-L1) expression on cancer cells is mainly regulated by Interferon-gamma (IFN-γ), which induces T cell exhaustion and enables tumor immune evasion. In this study, we demonstrate that acidosis, a common characteristic of solid tumors, significantly increases IFN-γ-induced PD-L1 expression on aggressive cancer cells, thus promoting immune escape. Using preclinical models, we found that acidosis enhances the genomic expression and phosphorylation of signal transducer and activator of transcription 1 (STAT1), and the translation of STAT1 mRNA by eukaryotic initiation factor 4F (elF4F), resulting in an increased PD-L1 expression. We observed this effect in murine and human anti-PD-L1-responsive tumor cell lines, but not in anti-PD-L1-nonresponsive tumor cell lines. In vivo studies fully validated our in vitro findings and revealed that neutralizing the acidic extracellular tumor pH by sodium bicarbonate treatment suppresses IFN-γ-induced PD-L1 expression and promotes immune cell infiltration in responsive tumors and thus reduces tumor growth. However, this effect was not observed in anti-PD-L1-nonresponsive tumors. In vivo experiments in tumor-bearing IFN-γ
mice validated the dependency on immune cell-derived IFN-γ for acidosis-mediated cancer cell PD-L1 induction and tumor immune escape. Thus, acidosis and IFN-γ-induced elevation of PD-L1 expression on cancer cells represent a previously unknown immune escape mechanism that may serve as a novel biomarker for anti-PD-L1/PD-1 treatment response. These findings have important implications for the development of new strategies to enhance the efficacy of immunotherapy in cancer patients.